(S (NP (JJ Recent) (NNS studies)) (VP (VBP have) (VP (VBN shown) (NP (NP (JJ promising) (NNS results)) (PP (IN in) (S (VP (VBG using) (NP (NNP Deep) (NNP Learning)) (S (VP (TO to) (VP (VB detect) (NP (NN malignancy)) (PP (IN in) (NP (ADJP (JJ whole) (NN slide)) (NN imaging)))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (PRP they)) (VP (VBD were) (VP (VBN limited) (PP (TO to) (S (VP (ADVP (RB just)) (VBG predicting) (NP (NP (ADJP (JJ positive) (CC or) (JJ negative)) (NN finding)) (PP (IN for) (NP (DT a) (JJ specific) (NN neoplasm))))))))) (. .))
(S (NP (PRP We)) (VP (VBD attempted) (S (VP (TO to) (VP (VB use) (NP (NNP Deep) (NNP Learning)) (PP (IN with) (NP (DT a) (JJ convolutional) (JJ neural) (NN network) (NN algorithm))) (S (VP (TO to) (VP (VB build) (NP (NP (DT a) (NN lymphoma) (JJ diagnostic) (NN model)) (PP (IN for) (NP (NP (CD four) (JJ diagnostic) (NNS categories)) (: :) (NP (NP (NN benign) (NN lymph) (NN node)) (, ,) (NP (VB diffuse) (JJ large) (NNP B) (NN cell) (NN lymphoma)) (, ,) (NP (NNP Burkitt) (NN lymphoma)) (, ,) (CC and) (NP (JJ small) (JJ lymphocytic) (NN lymphoma))))))))))))) (. .))
(S (NP (PRP$ Our) (NN software)) (VP (VBD was) (VP (VBN written) (PP (IN in) (NP (NNP Python) (NN language))))) (. .))
(S (NP (PRP We)) (VP (VBD obtained) (NP (NP (JJ digital) (JJ whole) (NN slide) (NNS images)) (PP (IN of) (NP (NP (NNP Hematoxylin) (CC and) (NNP Eosin) (VBD stained) (NNS slides)) (PP (IN of) (NP (NP (CD 128) (NNS cases)) (PP (VBG including) (NP (NP (CD 32) (NNS cases)) (PP (IN for) (NP (DT each) (JJ diagnostic) (NN category))))))))))) (. .))
(S (NP (NP (CD Four) (NNS sets)) (PP (IN of) (NP (NP (CD 5) (JJ representative) (NNS images)) (, ,) (NP (NP (CD 40x40) (NNS pixels)) (PP (IN in) (NP (NN dimension)))) (, ,)))) (VP (VBD were) (VP (VBN taken) (PP (IN for) (NP (DT each) (NN case))))) (. .))
(S (NP (NP (DT A) (NN total)) (PP (IN of) (NP (CD 2,560) (NNS images)))) (VP (VBD were) (VP (VBN obtained) (SBAR (WHPP (IN from) (WHNP (WDT which))) (S (S (NP (CD 1,856)) (VP (VBD were) (VP (VBN used) (PP (IN for) (NP (NN training)))))) (, ,) (S (NP (CD 464)) (PP (IN for) (NP (NN validation)))) (CC and) (S (NP (CD 240)) (PP (IN for) (NP (VBG testing)))))))) (. .))
(S (PP (IN For) (NP (NP (DT each) (NN test) (NN set)) (PP (IN of) (NP (CD 5) (NNS images))))) (, ,) (NP (DT the) (JJ predicted) (NN diagnosis)) (VP (VBD was) (VP (VBN combined) (PP (IN from) (NP (NP (NN prediction)) (PP (IN of) (NP (CD 5) (NNS images))))))) (. .))
(S (NP (DT The) (NN test) (NNS results)) (VP (VBD showed) (NP (JJ excellent) (JJ diagnostic) (NN accuracy)) (PP (PP (IN at) (NP (CD 95) (NN %)) (PP (IN for) (NP (JJ image-by-image) (NN prediction)))) (CC and) (PP (IN at) (NP (CD 10) (NN %)) (PP (IN for) (NP (JJ set-by-set) (NN prediction)))))) (. .))
(S (NP (DT This) (JJ preliminary) (NN study)) (VP (VBD provided) (NP (NP (DT a) (NN proof)) (PP (IN of) (NP (NN concept))) (PP (IN for) (S (VP (VBG incorporating) (NP (VBN automated) (RBR lymphoma) (JJ diagnostic) (NN screen)) (PP (IN into) (NP (JJ future) (NN pathology) (NN workflow))) (S (VP (TO to) (VP (VB augment) (NP (NP (DT the) (NNS pathologists) (POS â€º)) (NN productivity)))))))))) (. .))
